Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 201.00
+0.50 (0.25%)
Mar 6, 2026, 11:52 AM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 432.66 million as of March 6, 2026. Its market cap has decreased by -4.80% in one year.
Market Cap
432.66M
Enterprise Value
496.39M
Revenue
220.30M
Ranking
n/a
PE Ratio
48.07
Stock Price
201.00
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 432.66M, an increase of 3,795.36%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 433.74M | -7.76% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.14B |
| GSK plc | 83.21B |
| Haleon | 33.96B |
| Smith & Nephew | 11.10B |
| Spire Healthcare Group | 764.51M |
| Allergy Therapeutics | 728.24M |
| Craneware | 534.84M |
| Avacta Group | 310.56M |